Summary
Atrial fibrillation (AF) disease affects 7.8% of people ≥65 years old worldwide, and it is often associated with multimorbidity and polypharmacy. AF has a significant economic and societal impact on patients and healthcare systems. As a consequence, there is need for...
More information & hyperlinks
| Web resources: | https://ehra-paths.eu |